RxDoctor Payments Data

Bernard Lo, MD

Internal Medicine · San Francisco, CANPI 1184688137

Payments from drug & device makers

$87,200in general payments, 2019–2025

Across 76 payments — averaging $1147.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$87K

What the payments were for

  • Consulting fees$78,18190%
  • Travel & lodging$8,29810%
  • Food & beverage$7211%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Takeda Pharmaceuticals U.S.A., Inc.76$87,200

How this compares

$87,200 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Medicare billing

Part B allowed, 2024
$6,075
Medicare patients
13
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ValacyclovirValacyclovir Hcl13$950
Atorvastatin Calcium21$384
Benazepril Hcl11$255
Omeprazole12$212
Amlodipine Besylate19$142
Hydrochlorothiazide11$116
Tamsulosin Hcl12$81

Paid to pharmacies, not to this prescriber.

Other internal medicine in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →